Abstract-Higher organisms are able to respond to continuously changing external conditions by transducing cellular signals into specific regulatory programs, which control gene expression states of thousands of different genes. One of the central problems in understanding gene regulation is to decipher how combinations of transcription factors control sets of coexpressed genes under specific experimental conditions. Existing methods in this field mainly focus on sequence aspects and pattern recognition, e.g., by detecting cis-regulatory modules (CRMs) based on gene expression profiling data. We propose a novel approach by combining experimental data with a priori knowledge of respective experimental conditions. These various sources of evidence are likewise considered using multi-objective evolutionary optimization. In this work, we present three objective functions that are especially designed for stimulus-response experiments and can be used to integrate a priori knowledge into the detection of gene regulatory modules. This method was tested and evaluated on whole-genome microarray measurements of drug-response in human hepatocytes.
I. INTRODUCTION
Higher organisms are able to respond to permanently changing environmental conditions by activating specific generegulatory programs. These condition-specific regulatory programs consist of positively and negatively regulating transcription factors (TFs) and coordinate the expression of sets of functionally related genes [1] . Although much is known about gene-regulatory relationships, knowledge about conditionspecific regulatory programs is still limited. Genome-wide mRNA expression measurements, conducted under multiple experimental conditions, constitute powerful analytical tools to approach this challenge [1] , [2] . Current computational methods, for deciphering gene-regulatory programs from highthroughput data, are mostly based on the detection of cisregulatory modules (CRMs). CRMs are defined as patterns of transcription factor binding sites (TFBSs) that are present in promoter sequences of co-expressed genes. TFBSs are usually identified by mapping libraries of position frequency matrices (PFMs) to promoter sequences of genes. PFMs are widely used DNA-binding motif models that are mathematically represented as nucleotide frequency matrices [3] . The detection of common patterns of TFBSs makes it possible to draw conclusions about the transcription factors that cooperatively regulate the given set of genes [4] . Most CRM detection methods are restricted to mine for patterns of TFBSs at the sequence level and most often ignore the associated TFs and their relationships to the target genes on the mRNA expression level, which can partly be traced back to auto-regulatory transcriptional control mechanisms [5] . Recent approaches partly use these dependencies to discover regulatory relationships between TFs and their clustered target genes [6] , [7] . CRM detection is mostly approached using heuristic optimization techniques, such as evolutionary algorithms [8] , [9] . Alternative approaches mine for CRMs based on stochastic modeling using Bayesian Hidden Markov Models [10] . Most of these approaches, however, do not account for knowledge about the respective experimental conditions, like disease states, chemical stimuli, or other treatments. For this work, we developed a new algorithm that integrates multiple sources of biological knowledge, as gene expression profiles, position frequency matrices (PFMs), protein-protein interaction data, and proteinchemical interaction data into the search for CRMs. This is mathematically accomplished by formulating the search for CRMs as multi-objective optimization problem. Thus, the integration of additional sources of evidence drives the search for CRMs towards solutions that are specific for the underlying experimental condition. As depicted in Fig. 1 , we propose three different sources of evidence, which are implemented as objective functions: (1) patterns of TFBSs, (2) multivariate relationships between TFs and target genes, (3) pathway connectivity scores between TFs and experimental treatment. The method was tested and evaluated on a microarray dataset of drug-treated samples of human hepatocytes.
II. CIS-REGULATORY MODULE DETECTION
The integration of the above mentioned sources of evidence is realized by formulating the CRM detection problem as multi-objective optimization problem. In order to account for the combinatorial complexity of this problem, we propose multi-objective genetic algorithms (MOGAs), which are heuristic search procedures that are inspired by natural evolution. In general, genetic algorithms (GAs), sample the search space by generating candidate solutions based on the three main principles of evolution: natural selection, mutation and recombination; MOEAs have been proven to be powerful for solving complex optimization problems [11] , [12] . Multiobjective optimization problems are mathematically solved by investigating sets of so-called Pareto-optimal solutions, which represent appropriate solutions to the optimization problem that are not dominated by other solutions [11] . Since GAs are stochastic search procedures, different optimization runs may result in different solutions. In order to get robust results, the whole multi-objective optimization procedure is repeated multiple times. As depicted in Fig. 1 , the CRM-detection method expects as input sets of co-expressed genes, which can be derived from gene expression data by clustering [13] . The procedure is sub-divided into two main steps. In the first step, the promoter sequences of the input genes are scanned for TFBSs using libraries of PFMs. The resulting set of matching TFBSs constitutes the search space that is mined for CRMs by applying the MOGA in the second step. A.
Step I: Scan for TFBSs In this step, as depicted in Fig. 1 (Step I), position frequency matrices (PFMs) are used to scan promoter sequences for TFBSs and calculate binding scores at each position. According to Aerts et al. (2003) [14] , the binding score x (Θ) of a single PFM Θ on subsequence x of sequence can be calculated as
where denotes the nucleotide found at position in the subsequence x, Θ( , ) is the probability of finding according to PFM Θ and ( | ) gives the probability of finding according to the background model . is the length of the respective binding site. Eq. 1 calculates the likelihood that subsequence x is generated by the motif model with respect to the background model . One TF can bind at multiple different positions to the DNA. The different binding sites that are matched by a PFM Θ on sequence are referred to as instances of Θ on . Binding scores are calculated according to Eq. 1 using a 4 th -order hidden Markov model as background. In order to decide, if a certain score x (Θ) should be counted as match or not, cutoff levels need to be defined. Individual cutoff values are pre-calculated for each PFM individually rather than choosing a global cutoff score for all PFMs. To this end, a conservative cutoff strategy is implemented, which is based on scanning non-regulatory (i.e., exonic) sequences and calibrating the cutoff score such that no hits are found on non-regulatory sequences [15] . In this work, the databases JASPAR [16] and TRANSFAC [17] were used as PFM resources.
B. Step II: Multi-objective genetic algorithm
The core part of the proposed algorithm is to identify combinations of cooperatively regulating TFs for each cluster of genes. The crucial idea is to consider the problem of searching for CRMs in sets of co-expressed genes as a multiobjective combinatorial optimization problem, which allows us to combine various heterogeneous sources of evidence. Depending on the given microarray dataset, various sources of evidence come into consideration. In this work, we propose three different sources of evidence: (1) patterns of TFBSs, (2) relationships between regulators and clustered genes, and (3) pathway scores, representing the relationship between TFs and the respective experimental condition (see Fig. 1 ). Here, we propose a MOGA to search for optimal TF combinations for given clusters of genes. As described above, MOGAs search for so called Pareto-optimal solutions. To this end, as described in Section II-E, the final set of Pareto optimal solutions is evaluated by calculating genome-wide specificity scores.
1) First optimization objective:
The first criterion that a CRM has to meet is the consistence of multiple good matching PFMs that all occur within a bounded region within the promoter sequences of the input genes. These properties are reflected by the cluster module score (CMS). Let be the k th instance of TFBS Θ on sequence . The detection of a CRM can, according to Aerts et al. (2004) [8] , be performed by sampling the search space for combinations
of instances of TFBSs Θ 1 , ..., Θ that are found in sequence . The fitness of one possible solution m on a single sequence can be evaluated by calculating the sequence module score (SMS) as follows
Since TFBSs are assumed to lie in physical proximity in a promoter sequence, they are not allowed to overlap. Thus, the solution space of possible modules m = Let ( 1 , ..., ) be a set of promoter sequences that belong to a cluster c of co-expressed genes. The module score for a cluster of promoter sequences (CMS) can be calculated by adding up the SMS of single sequences :
Thus, the first objective 1 of the proposed CRM-detection algorithm is to find a module m * that maximizes the cluster module score CMS m (c), for a given cluster c:
2) Second optimization objective: Regulatory relationships between TFs and their target genes are often reflected at the mRNA level [5] and become visible in microarray experiments by strong correlations of their respective expression profiles. To this end, the multivariate relationship between TFs and their putative target genes (input genes) can serve as an additional source of evidence in the search for CRMs, which is realized by the second optimization objective.
be a candidate solution consisting of one instance of each of the PFMs Θ 1 , ..., Θ . Since every PFM Θ in our dataset is associated with a certain TF and we know the expression profiles of almost all TFs from the underlying whole-genome microarray dataset, we can include the multivariate relationship between the expression profiles of the transcription factors associated to a module m and the expression profile of the target genes in the cluster as second source of evidence. A multivariate linear regression is used to model the combinatorial regulatory relationship between the expression profiles of TF combinations in module m and their putative target genes in the cluster. Let Θ = (Θ 1 , ..., Θ ) be the expression profile of the associated TF to PFM Θ over all data points.
where y = ( 1 , ..., ) is the mean expression profile over all genes in cluster c, i.e., the cluster centroid. Since each cluster consists of highly correlated genes, taking the mean over all genes is reasonable at this point. The coefficient of determination 2 is used to quantify the degree of linear relationship.
2 ranges from 0 (no linear association) to 1 (perfect linear association). The sign of each regression coefficient in the regression solution indicates if the corresponding TF is a positive or negative regulator. The method of least squares is applied [18] to solve the regression problem. Thus, the second objective 2 is to find a module m * with maximal coefficient of determination 2 between the associated TFs and the cluster centroid y :
where
2 gives the residual variation, i.e., the difference between data points and regression
gives the variation of the dependent variable y .
3) Third optimization objective:
The activation of TFs is generally the response of the cell to external stimuli, e.g. hormones, endogenous or exogenous chemicals, which trigger signaling cascades that finally promote the TF activation. To this end, when stimulus-response data are analyzed, signaling cascades between the external stimulus and the candidate set of TFs can serve as additional source of evidence. In this work, the BowTieBuilder algorithm [19] is used to evaluate the connection between a candidate set of TFs and external stimuli (e.g., chemicals or hormones). The BowTieBuilder is a pathway inference algorithm that identifies the most confident pathway between two given sets of proteins, i.e., the set of source chemicals/proteins and set of target proteins (TFs) based on a given network of known protein-protein and protein-chemical interactions. To this end, interaction networks from the protein-protein interaction database STRING [20] and the protein-chemical interaction database STITCH [21] have been integrated. These databases contain known and predicted interactions that are either physical or functional. Each interaction is associated with a confidence score between 0 and 1 depending on the reliability of the information sources. Formally, the third objective function 3 is designed to assess the confidence of the interaction network between the respective stimulus and the set of TFs m of a module m. Therefore, the scores of the most confident interaction paths ( , ) from the stimulus to the TFs ∈ are averaged. Accordingly, the more confident the stimulus is connected to the TFs, the better is the fitness of the candidate solution. Thus, the third objective 3 is to find a module m * that maximizes the confidence of the pathway between the stimulus and the candidate TFs. It is calculated as follows:
C. Multi-objective genetic algorithm with Pareto ranking
The objectives 1 , 2 and 3 are not correlated and in some cases, but not generally, conflicting. We do not recommend to optimize them individually, because this could result in biologically unacceptable results. The optimization of the second objective 2 , for example, without insurance that the respective TFBSs occur in the promoter sequences ( 1 ) will produce correlation networks, which often contain biologically implausible relationships. Therefore, multi-objective optimization can be applied to simultaneously optimize all objective functions in order to obtain a set of Pareto-optimal solutions. A solution is said to be Pareto-optimal if it cannot be improved with respect to one objective without worsening another objective [11] . In this work, we use a MOGA with Pareto ranking to detect a set of Pareto-optimal solutions with respect to 1 , 2 and 3 . In Pareto ranking approaches, the population is ranked according to a dominance rule and the fitness value for each solution is assigned with respect to this ranking [22] . Here, we used a fast elitist non-dominated sorting genetic algorithm (NSGA-II) with crowding distance as proposed by Deb et al. [23] , [24] .
The algorithm starts with an initial population that consists of candidate modules m , which are randomly sampled from the pool of matching TFBSs. If the termination criterion is not satisfied, an offspring population ( ) is generated by applying crossover and mutation operators to the initial population ( ) and the fitness of all individuals according to both fitness functions is evaluated. The mutation and crossover operators are called with a mutation rate of 0.1 and a crossover rate of 0.7, respectively (see Discussion). Mutation of a candidate solution is performed by randomly changing one TFBS with probability 1 . A 1-point crossover strategy is used to recombine the TFBS-configurations of two candidate solutions m and m to a new candidate solution m . The fast non-dominated sorting algorithm NSGA-II is used to identify the non-dominated fronts 1 , ..., to rank the population in ascending order. Crowding distances with respect to Pareto ranking and crowding distance [23] . Binary tournament selection, based on the crowding distances [24] , is used to create the parent population ( +1) from . If the termination criterion is satisfied, all solutions stored in archive are returned to the user. The termination criterion is satisfied if = 30, 000 iterations have been evaluated or 5, 000 fitness evaluations did not yield any change to the Pareto front. We used the NSGA-II implementation of EvA2 [25] , which is a comprehensive heuristic optimization workbench implemented in Java TM . EvA2 provides several optimization methods, such as evolution strategies, genetic algorithms, differential evolution, particle swarm optimization, as well as classical techniques such as multi-start hill climbing or simulated annealing [25] .
D. Complexity
The size of the search space, and therefore the complexity of the combinatorial optimization problem, strongly depends on the following variables: (1) module size , which has to be pre-defined (2) promoter sequence size, and (3) PFM cutoff strategy. Let be number of PFM matches in all promoter sequences of one cluster and be the maximum module size. The size of the search space Ω consists of all -element subsets of :
The maximal number of different TFs within a CRM and the promoter size are strongly organism-and tissue-specific and therefore strongly depend on the underlying dataset. directly influences the size of the search space according to Eq. 8. The promoter size influences the number of matching PFMs after scan for TFBSs. Short promoter sequences of 1, 000 base pairs, as used in this work, lead to a relatively small compared to promoter sequences of 10, 000 base pairs and more. All fitness functions proposed in this work can be calculated in reasonable time. The speed-determining optimization step is the evaluation of objective function 3 . This evaluation can be accelerated substantially by pre-calculating all shortest pathways between the disposed PFM library and the given stimulus and storing them in a look-up table. A module search in a gene cluster of about 20 genes with about 1, 000 potential transcription factors including 30, 000 generations can be performed in less than one day on an average dual core processor. In practice, convergence is most often reached after 10, 000 generations. Considering that it is impossible to test thousands of combinatorial TF relationships for a given gene cluster in a wet-lab approach, we feel it is well worth the wait, as the approach is providing new testable hypotheses.
E. Final specificity ranking
Multi-objective optimization algorithms generate, as mentioned above, not one single solution, but sets of Pareto optimal solutions. During optimization, NSGA-II with crowding distance was used to rank these Pareto optimal solutions, which is reasonable due to its rapid calculation. For the final set of solutions, however, we want to select a solution that is as close as possible to biology. According to Loo et al., we define a CRM solution as biologically meaningful if it is specific for the gene cluster it was derived from [9] . To this end, we perform a genome-wide backwards search for each Pareto optimal solution and rank all genes in the genome according to presence and fitness of the respective CRM in each promoter of the genome. Then, the ranks of all genes of the given cluster are determined to derive a specificity score, which is defined as the rank of the worst gene of the respective cluster in the genome-wide ranking. The most specific CRM, i.e., the one with the best specificity score, is recognized as the final solution. This genome-wide ranking Table 1 ), which are for the most part involved in steroide metabolism (b) CRM-detection distills a combination of 5 different TFs, i.e., SP1, SP3, MAZ, KLF4, and NFYA. (c) Evaluation of the objective function 3 reveals several co-factors and signaling molecules that are putatively involved in pravastatinresponsive regulatory mechanisms. The interaction of SP1, SP3 and HDAC2, for instance, has been reported previously [28] . KLF4 and NFYA are well known regulators of cholesterol and steroid metabolism [29] , [30] . MAZ has not been reported before in the context of statin exposure.
procedure is computationally demanding and can therefore only be performed as a post-processing step.
III. APPLICATION TO A Homo sapiens DRUG-RESPONSE

DATASET
The multi-objective CRM-detection procedure was applied to a whole-genome microarray (Affymetrix U133 plus 2.0 chip) dataset of primary human hepatocytes from six individuals. Each sample was treated with pravastatin, a cholesterol lowering drug, and the control substance dimethylsulfoxide (DMSO). Microarray measurement were performed at up to six different time points (i.e., 0 h, 6 h, 12 h, 24 h, 48 h and 72 h) after the drug stimulus (measurements were conducted at the Microarray Facility Tuebingen, Germany). Microarray preprocessing, i.e., normalization, background correction and detection of differentially expressed genes, was conducted using standard procedures implemented in R Bioconductor [26] . Details about these experiments and the resulting dataset are described in [27] .
A. Clustering
The Extended Dimension Iterative Signature Algorithm (EDISA) was used to find clusters of co-expressed genes. EDISA is a 3D clustering algorithm that is designed for genecondition-time datasets, i.e., multiple experimental conditions performed at various time points [13] , and mines the microarray data for subsets of genes, which are highly correlated over time. This algorithm is able to deal with subject-individual variability of gene expression profiles, which is often neglected in microarray analysis. EDISA is a heuristic search procedure that expects two main input parameters. The parameter defines the required similarity of each gene to the average trajectory of the cluster. The variable specifies required similarity of each condition with the average trajectory of the cluster. The number of clusters is not predefined but, as discussed in Supper et al. [13] , strongly depends on the configuration of these input parameters as well as the strucure of the underlying dataset. As depicted in Table 1 , EDISA identified 10 different clusters consisting of between 15 and 40 different genes.
In order to assess if sets of co-expressed genes are functionally related, gene set enrichment analysis was applied. To this end, a hypergeometric test was performed to each cluster of genes, testing for different Gene Ontology [31] categories and KEGG pathways [32] . In 8 of 10 clusters, genes of steroid-, lipid-and drug metabolism were found to be significantly enriched at significance level = 0.05 after Sidak multiple testing adjustment [33] .
B. Application of multi-objective CRM-detection
For each cluster of co-expressed genes, up to five TFs were identified using the multi-objective algorithm presented above. The proximal promoter sequences (1, 000 base pairs upstream from the transcription start site) were scanned using a window size of 200 base pairs. The CRM-detection method was run using all three fitness functions proposed above, whereas 3 was configured to calculate pathway connectivity scores between the TFs of each candidate solution and the drug stimulus. In order to speed up the calculation of this function, shortest pathways between all individual TFs and drug stimulus are pre-calculated based on the databases STRING and STITCH [20] , [21] . The optimization was started with a maximum number of 30, 000 evaluations of each objective function. Finally, the the Pareto optimal solutions were ranked according to the final ranking procedure presented above. All of the resulting CRMs contained several TFs that are well known in the context of statin exposure. Among the most frequent TFs are Kruppel-like factors (e.g., KLF4 and KLF11), as well as forkhead transcription factors (e.g., FOXD3, FOXO3). KLFs have previously been published in the context of statins [34] , [35] and were recently found to be involved in the adipogenesis pathway [30] , [36] . The hypoxia inducible factor 1 (HIF1A) was previously found to be involved in the regulation of the ATP-binding cassette (ABCA1) and plays a role in hypoxia mediated inhibition of cholesterol synthesis [37] , [38] . As an example, the BTD, NFYA, SP4, HIF1A, SP1
CRM-detection results of cluster 9 are depicted in Fig. 2 . As depicted in Fig. 2 (c) , several pravastatin specific TFs were found for steroid metabolism cluster 9, i.e., MAZ, KLF4, SP1, SP3 and NFYA. The detected TFs, i.e., NFYA, KLF4, SP1, and SP3 are known regulators of steroid metabolism in the context of statin treatment [28] , [29] , [35] . The MYC-associated zinc finger protein (MAZ) has not been reported before in this context. The complete multi-objective CRM-detection experiments were robustly replicated using 10 multi-runs.
IV. IMPLEMENTATION AND AVAILABILITY
The new algorithm proposed in this work is entirely implemented in Java TM , from which the following libraries and external programs are called: EvA2 [25] , BioJava [39] and RSA-Tools [40] . It is integrated into a computational workbench, which supports nearly every step in the process from microarray gene expression data to the final CRMs [41] . The program is capable of retrieving sequences, performing TFBS scans on these sequences and finally, searching for CRMs. It can be launched via Java TM web start and possesses a graphical user interface based on SWT. For large datasets, the program is able to create jobs and processes them in parallel from the command line on various computer cluster systems. The results can be evaluated, visualized and validated in many ways. For more information on the program, please see the applications note [41] and the documentation which is also available from the URL stated below. The program is free of charge and can be accessed via the following link: http://www.ra.cs.uni-tuebingen.de/software/ModuleMaster/.
V. DISCUSSION
The main idea behind this work is based on the observation that TFs and their target genes often correlate at the gene expression level. It provides a new mathematical concept to combine both sources of evidence in an appropriate way. The main outcome of this work is a new method for the detection of CRMs that can be used for the reconstruction of transcriptional regulatory networks from microarray data. The proposed method consists of a computational framework that covers all steps from promoter retrieval through CRM detection, CRM evaluation and transcriptional network visualization. The algorithm expects several crucial input parameters, which depend on the underlying dataset and need therefore to be specified by the user, i.e., promoter length and module size . The length of promoter sequences strongly depends on the complexity of the underlying organism and the size of intergenic sequences contained in the genomes. For higher organisms (e.g. human) regulatory sequences may be several thousand base pairs long, whereas for lower organisms (e.g. yeast) promoter sequences may consist of only several hundred base pairs [42] , [43] . Furthermore, promoter sequences may vary substantially even within organisms and depend on the orientation of the genes towards each other. Also the CRM sizes might strongly depend on the complexity of the model organism. Therefore, on the one hand side, promoter length and module size should be determined according to such biological issues. On the other hand, it should be kept in mind that both parameters strongly influence the size of the search space and, hence, the chance to find biologically meaningful results. For example, we took the human proximal promoters (1,000 bp upstream of the transcription start site) for two reasons: important regulation of human promoters by multiple TFs does occur close to the transcription start although some enhancers can be much farther away, and to reduce the overall complexity for the computational problem. Depending on how one generates their clusters of genes and therefore how many are obtained, the average molecular biologist can obtain new candidates for testing in the laboratory within short time compared to months and years sometimes needed in traditional molecular biology. Moreover, the success of this method depends on the amount and quality of PFMs that are characterized experimentally and used as a priori knowledge. If there are only few PFMs known for a certain organism, it does not make sense to screen for large sized cis-regulatory modules. As mentioned above, also the PFM cutoff strategy should be chosen according to these issues. The core algorithm is a MOGA, which optimizes three heterogeneous objectives in order to find biologically meaningful regulatory relationships. These objectives are neither correlated nor directly opposed. Additionally, no general preference of one objective over the other can be made in advance. Thus, Pareto-optimal solutions returned by the algorithm should be ranked according to their specificity. Since genetic algorithms are stochastic optimization procedures, the solutions of different runs may differ when different random seeds are used. Depending on the search space, the algorithm returns stable results, i.e., more or less the same solutions are found when the procedure is repeated multiple times. In genetic algorithms recombination is the main search operator. To this end, the crossover rate is usually set to values between 0.7 and 1 [44] , [45] . In order to avoid the loss of genetic variants, a certain amount of mutation is essential for any genetic algorithm but is usually very small. In this work, the crossover operator was applied with a probability 0.7 and the mutation operator was called with probability of 0.1, which are the default settings of the EvA2 workbench [25] . The actual probability of changing one bit after calling the mutation operator is set to 1 according to [46] . In the end, all these parameters strongly depend on the specific optimization problem, i.e., on the complexity of the organism, the amount of available PFMs, and the underlying microarray dataset. The best parameter combinations can theoretically be determined by a grid search, which is computationally demanding. If a parameter grid search is computationally not feasible for a given problem, we recommend to use the default parameters of the EvA2 evolutionary optimization workbench [25] . As proposed in the applications note [41] , the user may specify all parameters mentioned above through a graphical user interface and adapt them according to the particular optimization problem. This also holds for the termination criterion, which was set to 30, 000 overall evaluations or 5, 000 evaluations without Pareto front changes and is based on the observation that in most cases (i.e., all clusters within three different datasets) convergence has been achieved before the first 10, 000 fitness evaluations.
VI. CONCLUSION
In this work, we present a new algorithm for the detection of cis-regulatory modules and for the reconstruction of transcriptional regulatory networks from sets of co-expressed genes. The novelty of our approach is the integration of three sources of evidence: (1) patterns of transcription factor binding sites, (2) multivariate linear relationships between transcription factors and their target genes, and (3) pathway connectivity scores based on protein-protein-and protein-chemical interaction data. We show here, that multi-objective evolutionary optimization is well suited for the integration of heterogeneous sources of evidence to find new regulatory dependencies. A multitude of known specific regulatory relationships in Homo sapiens drug-response data was successfully confirmed.
